Research ArticleCARDIOVASCULAR
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo
Delvin R. Knight, Andrew H. Smith, David M. Flynn, Joseph T. MacAndrew, Suzanne S. Ellery, Jimmy X. Kong, Ravi B. Marala, Ronald T. Wester, Angel Guzman-Perez, Roger J. Hill, William P. Magee and W. Ross Tracey
Journal of Pharmacology and Experimental Therapeutics April 2001, 297 (1) 254-259;
Delvin R. Knight
Andrew H. Smith
David M. Flynn
Joseph T. MacAndrew
Suzanne S. Ellery
Jimmy X. Kong
Ravi B. Marala
Ronald T. Wester
Angel Guzman-Perez
Roger J. Hill
William P. Magee
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 297, Issue 1
1 Apr 2001
Research ArticleCARDIOVASCULAR
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo
Delvin R. Knight, Andrew H. Smith, David M. Flynn, Joseph T. MacAndrew, Suzanne S. Ellery, Jimmy X. Kong, Ravi B. Marala, Ronald T. Wester, Angel Guzman-Perez, Roger J. Hill, William P. Magee and W. Ross Tracey
Journal of Pharmacology and Experimental Therapeutics April 1, 2001, 297 (1) 254-259;
Research ArticleCARDIOVASCULAR
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo
Delvin R. Knight, Andrew H. Smith, David M. Flynn, Joseph T. MacAndrew, Suzanne S. Ellery, Jimmy X. Kong, Ravi B. Marala, Ronald T. Wester, Angel Guzman-Perez, Roger J. Hill, William P. Magee and W. Ross Tracey
Journal of Pharmacology and Experimental Therapeutics April 1, 2001, 297 (1) 254-259;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement